Meropenem
Sold as Meronem, Ap meropenem, Meroject, Aspen meropenem, Merospira, Ran-meropenem, Mercide, Adco-meropenem iv, Covan-meropenem iv, Meropenem restan iv, Mertic, Meropenem sandoz, Meropenem safeline, Meropenem teva, Mercarb, Meronact iv, Merobax, Merozin, Meropenem austell registration, Meropenem austell
(4R,5S,6S)-3-[(3S,5S)-5-(Dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
Drag to rotate. Structure from PubChem CID 441130.
Background
Registration
- Applicants
- 12
- Registrations
- 35
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Pfizer Laboratories (Pty) Ltd | Meronem, Merospira | 500 mg, 1000 | 290340, 290341, 430629 | S4 | None |
| Pharmacare limited û woodmead | Ap meropenem | 1 g | 420176 | S4 | None |
| Pharma Dynamics (Pty) Ltd | Meroject | 1 g, 500 mg | 420280, 420281 | S4 | None |
| Acino Pharma (Pty) Ltd | Aspen meropenem | 1 g, 500 mg | 420697, 420698 | S4 | None |
| Ranbaxy (SA) (Pty) Ltd2 of 4 cancelled | Ran-meropenem, Mercide | 1 g, 500 | 430767, 430768, 430769, 430770 | S4 | None |
| Adcock Ingram Critical Care (Pty) Ltd4 of 6 cancelled | Adco-meropenem iv, Covan-meropenem iv, Meropenem restan iv | 000 mg 1, 500 mg | 440206, 440207, 440301, 440302, 440303, 440304 | S4 | None |
| Sandoz South Africa (Pty) LtdCancelled | Mertic, Meropenem sandoz | 1 g, 500 mg | 450417, 450418, 450419, 450420 | S4 | None |
| Safeline Pharmaceuticals (Pty) LtdCancelled | Meropenem safeline | 1g, 500 mg | 460508, 460509 | S4 | None |
| Teva Pharmaceuticals (Pty) LtdCancelled | Meropenem teva | 1 g, 500 mg | 470177, 470178 | S4 | None |
| Austell Pharmaceuticals (Pty) Ltd | Mercarb, Meropenem austell registration, Meropenem austell | 000 mg 1, 500, 500 mg 2, 1000 | 500178, 500179, 580258, 580259 | S4 | None |
| Activo Health (Pty) Ltd | Meronact iv | 1 000 | 560982 | S4 | None |
| Abex Pharmaceutica (Pty) Ltd | Merobax, Merozin | 500, 1000 | 570512, 570513, 570514.512, 570515.513 | S4 | PIPIL |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Meronem 500 EACH VIAL CONTAINS MEROPENEM TRIHYDRATE EQUIVALENT TO MEROPENEM ANHYDROUS 500 mg | 500 | 29034029/20.1.1/0340 | Registered | S4 | None |
| Meronem 1000 EACH VIAL CONTAINS MEROPENEM TRIHYDRATE EQUIVALENT TO MEROPENEM ANHYDROUS 1000 mg | 1000 | 29034129/20.1.1/0341 | Registered | S4 | None |
| Ap meropenem 1 g EACH VIAL CONTAINS MEROPENEM TRIHYDRATE EQUIVALENT TO MEROPENEM 1000,0 mg | 1 g | 42017642/20.1.1/0176 | Registered | S4 | None |
| Meroject 500 MG EACH VIAL CONTAINS MEROPENEM TRIHYDRATE EQUIVALENT TO MEROPENEM 500,0 mg | 500 mg | 42028042/20.1.1/0280 | Registered | S4 | None |
| Meroject 1 g EACH VIAL CONTAINS MEROPENEM TRIHYDRATE EQUIVALENT TO MEROPENEM 1,0 g | 1 g | 42028142/20.1.1/0281 | Registered | S4 | None |
| Aspen meropenem 500 MG EACH VIAL CONTAINS MEROPENEM TRIHYDRATE EQUIVALENT TO MEROPENEM 500,0 mg | 500 mg | 42069742/20.1.1/0697 | Registered | S4 | None |
| Aspen meropenem 1 g EACH VIAL CONTAINS MEROPENEM TRIHYDRATE EQUIVALENT TO MEROPENEM 1,0 g | 1 g | 42069842/20.1.1/0698 | Registered | S4 | None |
| Merospira 500 MG EACH VIAL CONTAINS MEROPENEM TRIHYDRATE EQUIVALENT TO MEROPENEM 500,0 mg | 500 mg | 43062943/20.1.1/0629 | Registered | S4 | None |
| Ran-meropenem 500 EACH VIAL CONTAINS MEROPENEM 500,0 mg | 500 | 43076743/20.1.1/0767 | Cancelled | S4 | None |
| Ran-meropenem 1 g EACH VIAL CONTAINS MEROPENEM 1,0 g | 1 g | 43076843/20.1.1/0768 | Cancelled | S4 | None |
| Mercide 500 EACH VIAL CONTAINS MEROPENEM 500,0 mg | 500 | 43076943/20.1.1/0769 | Registered | S4 | None |
| Mercide 1 g EACH VIAL CONTAINS MEROPENEM 1000,0 mg | 1 g | 43077043/20.1.1/0770 | Registered | S4 | None |
| Adco-meropenem 500 MG iv EACH VIAL CONTAINS: MEROPENEM TRIHYDRATE EQUIVALENT TO MEROPENEM 500,0 mg | 500 mg | 44020644/20.1.1/0206 | Registered | S4 | None |
| Covan-meropenem 500 MG iv EACH VIAL CONTAINS MEROPENEM TRIHYDRATE EQUIVALENT TO MEROPENEM 500,0 mg | 500 mg | 44020744/20.1.1/0207 | Cancelled | S4 | None |
| Meropenem restan 500 MG iv EACH VIAL CONTAINS MEROPENEM TRIHYDRATE EQUIVALENT TO MEROPENEM 500,0 mg | 500 mg | 44030144/20.1.1/0301 | Cancelled | S4 | None |
| Meropenem restan 1 000 MG iv EACH VIAL CONTAINS MEROPENEM TRIHYDRATE EQUIVALENT TO MEROPENEM 1 000,0 mg | 000 mg 1 | 44030244/20.1.1/0302 | Cancelled | S4 | None |
| Adco-meropenem 1 000 MG iv EACH VIAL CONTAINS :MEROPENEM TRIHYDRATE EQUIVALENT TO MEROPENEM 1 000,0 mg | 000 mg 1 | 44030344/20.1.1/0303 | Registered | S4 | None |
| Covan-meropenem 1 000 MG iv EACH VIAL CONTAINS MEROPENEM TRIHYDRATE EQUIVALENT TO MEROPENEM 1 000,0 mg | 000 mg 1 | 44030444/20.1.1/0304 | Cancelled | S4 | None |
| Mertic 500 MG EACH VIAL CONTAINS MEROPENEM TRIHYDRATE EQUIVALENT TO MEROPENEM 500,0 mg | 500 mg | 45041745/20.1.1/0417 | Cancelled | S4 | None |
| Mertic 1 g EACH VIAL CONTAINS MEROPENEM TRIHYDRATE EQUIVALENT TO MEROPENEM 1,0 g | 1 g | 45041845/20.1.1/0418 | Cancelled | S4 | None |
| Meropenem sandoz 500 MG EACH VIAL CONTAINS MEROPENEM TRIHYDRATE EQUIVALENT TO MEROPENEM 500,0 mg | 500 mg | 45041945/20.1.1/0419 | Cancelled | S4 | None |
| Meropenem sandoz 1 g EACH VIAL CONTAINS MEROPENEM TRIHYDRATE EQUIVALENT TO MEROPENEM 1,0 g | 1 g | 45042045/20.1.1/0420 | Cancelled | S4 | None |
| Meropenem safeline 500 MG EACH VIAL CONTAINS MEROPENEM TRIHYDRATE EQUIVALENT TO MEROPENEM ANHYDROUS 500,0 mg | 500 mg | 46050846/20.1.1/0508 | Cancelled | S4 | None |
| Meropenem safeline 1g EACH VIAL CONTAINS MEROPENEM TRIHYDRATE: EQUIVALENT TO MEROPENEM ANHYDROUS 1,0 g | 1g | 46050946/20.1.1/0509 | Cancelled | S4 | None |
| Meropenem 500 MG teva EACH VIAL CONTAINS :MEROPENEM TRIHYDRATE EQUIVALENT TO MEROPENEM 500,0 mg | 500 mg | 47017747/20.1.1/0177 | Cancelled | S4 | None |
| Meropenem 1 g teva EACH VIAL CONTAINS :MEROPENEM TRIHYDRATE EQUIVALENT TO MEROPENEM 1 000,0 mg | 1 g | 47017847/20.1.1/0178 | Cancelled | S4 | None |
| Mercarb 500 EACH VIAL CONTAINS: MEROPENEM TRIHYDRATE EQUIVALENT TO MEROPENEM ANHYDROUS 500,0 mg | 500 | 50017850/20.1.1/0178 | Registered | S4 | None |
| Mercarb 1000 EACH VIAL CONTAINS: MEROPENEM TRIHYDRATE EQUIVALENT TO MEROPENEM ANHYDROUS 1000,0 mg | 1000 | 50017950/20.1.1/0179 | Registered | S4 | None |
| Meronact iv 1 000 EACH VIAL CONTAINS MEROPENEM TRIHYDRATE EQUIVALENT TO ANHYDROUS MEROPENEM 1 000,0 mg | 1 000 | 56098256/20.1.1/0982 | Registered | S4 | None |
| Merobax 500 Each Vial contains: Meropenem Trihydrate equivalent to Meropenem 500,0 mg | 500Powder for solution for injection or infusion | 57051257/20.1.1/0512Approved 5 August 2025 | Registered | S4 | PIPIL |
| Merobax 1000 Each Vial contains: Meropenem Trihydrate equivalent to Meropenem 1000,0 mg | 1000Powder for solution for injection or infusion | 57051357/20.1.1/0513Approved 5 August 2025 | Registered | S4 | PIPIL |
| Merozin 500 Each Vial contains: Meropenem Trihydrate equivalent to Meropenem 500,0 mg | 500Powder for solution for injection or infusion | 570514.51257/20.1.1/0514.512Approved 28 August 2025 | Registered | S4 | PIPIL |
| Merozin 1000 Each Vial contains: Meropenem Trihydrate equivalent to Meropenem 1000,0 mg | 1000Powder for solution for injection or infusion | 570515.51357/20.1.1/0515.513Approved 28 August 2025 | Registered | S4 | PIPIL |
| Meropenem 500 MG austell 2. Registration EACH VIAL CONTAINS: MEROPENEM TRIHYDRATE EQUIVALENT TO: MEROPENEM ANHYDROUS 500,0 mg | 500 mg 2. | 58025858/20.1.1/0258 | Registered | S4 | None |
| Meropenem 1 000 MG austell EACH VIAL CONTAINS: MEROPENEM TRIHYDRATE EQUIVALENT TO: MEROPENEM ANHYDROUS 1 000,0 mg | 000 mg 1 | 58025958/20.1.1/0259 | Registered | S4 | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Meropenem trihydrate equivalent to meropenem anhydrous
S4: Meropenem
Consolidated Schedules 06 July 2026, line 7068
Pharmacological class: Broad and medium spectrum antibiotics. (class 20.1.1)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Merobax 500, Abex Pharmaceutica (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.